Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 1 |
2015 | 1 |
2016 | 1 |
2020 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Cerebral amyloid angiopathy: clinical presentations and management challenges in the Australian context.
Intern Med J. 2023 Jun;53(6):907-916. doi: 10.1111/imj.15999. Epub 2023 Jan 13.
Intern Med J. 2023.
PMID: 36565446
Review.
Cerebral amyloid angiopathy (CAA) is a disease with several clinical manifestations. It is characterised by amyloid-beta deposition in cerebral blood vessels, making them prone to bleeding. ...
Cerebral amyloid angiopathy (CAA) is a disease with several clinical manifestations. It is characterised by amyloid …
Sensitivity of the Edinburgh Criteria for Lobar Intracerebral Hemorrhage in Hereditary Cerebral Amyloid Angiopathy.
van Etten ES, Kaushik K, van Zwet EW, Voigt S, van Walderveen MAA, van Buchem MA, Terwindt GM, Wermer MJH.
van Etten ES, et al.
Stroke. 2020 Dec;51(12):3608-3612. doi: 10.1161/STROKEAHA.120.031264. Epub 2020 Nov 5.
Stroke. 2020.
PMID: 33148142
BACKGROUND AND PURPOSE: The Edinburgh computed tomography and genetic criteria enable diagnosis of cerebral amyloid angiopathy (CAA) associated lobar intracerebral hemorrhage (ICH) but have not been validated in living patients. We assessed the sensitivity of …
BACKGROUND AND PURPOSE: The Edinburgh computed tomography and genetic criteria enable diagnosis of cerebral amyloid angiopa …
Item in Clipboard
ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.
Montañola A, de Retana SF, López-Rueda A, Merino-Zamorano C, Penalba A, Fernández-Álvarez P, Rodríguez-Luna D, Malagelada A, Pujadas F, Montaner J, Hernández-Guillamon M.
Montañola A, et al.
Neuromolecular Med. 2016 Mar;18(1):99-108. doi: 10.1007/s12017-015-8381-7. Epub 2015 Dec 14.
Neuromolecular Med. 2016.
PMID: 26661731
The involvement of apolipoproteins, such as the ApoE4 isoform, in Alzheimer's disease (AD) and cerebral amyloid angiopathy (CAA) highlights the fact that certain lipid carriers may participate in soluble beta-amyloid (Abeta) transport. ...
The involvement of apolipoproteins, such as the ApoE4 isoform, in Alzheimer's disease (AD) and cerebral amyloid angiopathy …
Item in Clipboard
Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y, Gibbons L, Pritchard A, Hardicre J, Wren J, Tian J, Shi J, Stopford C, Julien C, Thompson J, Payton A, Thaker U, Hayes AJ, Iwatsubo T, Pickering-Brown SM, Pendleton N, Horan MA, Burns A, Purandare N, Lendon CL, Neary D, Snowden JS, Mann DM.
Davidson Y, et al.
J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):515-7. doi: 10.1136/jnnp.2005.063917.
J Neurol Neurosurg Psychiatry. 2006.
PMID: 16543533
Free PMC article.
Genetic variations represent major risk factors for Alzheimer's disease (AD). While familial early onset AD is associated with mutations in the amyloid precursor protein and presenilin genes, only the e4 allele of the apolipoprotein E (APOE) gene has so far been est …
Genetic variations represent major risk factors for Alzheimer's disease (AD). While familial early onset AD is associated with mutati …
Item in Clipboard
Cite
Cite